Document is current
Any future updates will be listed below
-
Authors
Erfurth, Andreas
- License Information
-
More Information
Article History
Accepted: 20 August 2024
First Online: 17 October 2024
Interessenkonflikt
: A. Erfurth: Vorträge und/oder Advisory Boards für Angelini, Boehringer Ingelheim, Idorsia, Janssen, Lundbeck, Mylan, Neuraxpharm, Recordati und Sandoz.
Free to read: This content has been made available to all.
